APA (7th ed.) Citation

Y, K., R, A., A, S., M, Y., R, H., M, K., . . . M, K. (2026). Factors related to seroconversion of anti-cyclic citrullinated peptide antibody after the onset of rheumatoid arthritis: A case-control study and systematic review. Immunological medicine, 49(1), 76. https://doi.org/10.1080/25785826.2025.2565020

Chicago Style (17th ed.) Citation

Y, Kosumi, Asano R, Sugano A, Yoshimura M, Hisada R, Kono M, Fujieda Y, Atsumi T, and Kato M. "Factors Related to Seroconversion of Anti-cyclic Citrullinated Peptide Antibody After the Onset of Rheumatoid Arthritis: A Case-control Study and Systematic Review." Immunological Medicine 49, no. 1 (2026): 76. https://doi.org/10.1080/25785826.2025.2565020.

MLA (9th ed.) Citation

Y, Kosumi, et al. "Factors Related to Seroconversion of Anti-cyclic Citrullinated Peptide Antibody After the Onset of Rheumatoid Arthritis: A Case-control Study and Systematic Review." Immunological Medicine, vol. 49, no. 1, 2026, p. 76, https://doi.org/10.1080/25785826.2025.2565020.